Allergy/Asthma News

Pure fruit juice consumption was associated with asthma prevalence at age 11 years, but not at later ages or with overall asthma prevalence from age 11 to 20 years, according to data published in Preventive Medicine Report.

Evidence-based care informed by digital data collection led to a lower treatment burden among patients with severe, uncontrolled asthma, researchers reported at the European Respiratory Society International Congress.

Gov. Mike Parson of Missouri has signed SB 710, which authorizes all school personnel in the state trained by a nurse to administer epinephrine via autoinjector to any student experiencing anaphylaxis without any civil liability.

The COVID-19 pandemic provoked anxiety across the nation for many reasons, but patients with food allergies faced increases in very specific fears, according to a study in The Journal of Allergy and Clinical Immunology: In Practice.

Two trials that did not require oral food challenges to qualify participants for oral immunotherapy for peanut allergies achieved safety profiles that resembled those of earlier trials using these challenges, according to a study.

Sublingual immunotherapy does more than relieve symptoms of respiratory allergy in children. It also modifies the disease, according to a review published in Allergy and Asthma Proceedings as part of its Allergen Immunotherapy (AIT) Primer.

Obesity, fractional exhaled nitric oxide and maximum bronchodilator reversibility were among the factors that precited lower FEV1 over time among children with asthma, according to a study in The Journal of Allergy and Clinical Immunology.

Social, economic and environmental factors at individual and neighborhood levels mediated racial disparities in pediatric visits to the ED related to asthma, according to a study published in The Journal of Allergy and Clinical Immunology.

The use of immunotherapy among patients with multiple allergies and comorbidities not only is prevalent, but it also is linked to higher satisfaction with health care professionals, according to a survey conducted by Health Union.

A single dose of immunotherapy treatment prevented reductions in FEV1 among patients with cat allergies and mild asthma, according to a study published in The Journal of Allergy and Clinical Immunology.